Summary.-Wistar rats were sensitized to rat embryonic tissue by immunization with irradiated (5000rad) rat embryo cells (2 x 106 s.c. + 1 x 106 i.p.) derived from embryos aged 14-15 days, or by implantation of irradiated (5000 rad) tissue grafts from these embryos. Three to five immunizations were given at weekly intervals, and the rats were then challenged subcutaneously 7-10 days after the final inoculum with minimal tumour-producing tumour cell doses. Immunization with irradiated rat embryo cells failed to influence the growth and development of tumour cells prepared from hepatoma D23 and D30, sarcoma Mc57, mammary carcinoma AAF57 or cells prepared from spontaneously arising mammary carcinomata Sp4 and Spl5. Using adoptive transfer techniques, lymphoid cells from embryo-sensitized rats, when used in a 3000 :1 ratio (lymphoid cells: tumour cells), were shown effectively to retard the growth of hepatoma D23 in 3 out of 7 experiments performed. Similar adoptive transfer procedures proved ineffective in preventing the growth of mammary carcinoma AAF57. Using in vitro cytotoxicity tests, lymph node cells and spleen cells from embryo-immunized rats were shown to be cytotoxic for several rat tumour cell targets: hepatoma D23 (7/10 tests), sarcoma Mc7 (8/12 tests), mammary carcinoma AAF57 (2/2 tests) and Sp4 (3/4 tests), and for 14-15-day-old rat embryo cells (5/10 tests). In comparative tests lymphoid cells were relatively non-cytotoxic for 20-day-old rat embryo cells (1/6 tests) or cells prepared from adult rat lung or kidney (1/10 tests). The role of embryonic antigen(s) in tumour rejection is discussed.
IT IS NOW generally accepted that many virus-and chemically-induced animal tumours express embryonic antigens and these can be readily demonstrated using in vitro techniques (Baldwin, Glaves and Vose, 1973; Coggin and Anderson, 1974) . Using syngeneic animal tumour models, lymph node cells from multiparous pregnant animals have been shown to be reactive towards chemically-induced murine sarcoma cell lines, compared with lymph node cells from age-matched virgin controls (Brawn, 1970 (Brawn, , 1971 . Similar findings have been reported by Girardi et al. (1973) using DNA-virus-induced tumours, and by Baldwin et al. (1973) in chemically-induced rat hepatoma and sarcoma systems.
Attempts by different groups of workers to demonstrate transplant resistance to tumours following immunization with syngeneic embryonic tissue have not been uniformly successful. Failure to induce immunity to challenge with chemicallyinduced tumour cells in inbred mice immunized with syngeneic non-irradiated foetal tissue has been reported (Buttle and Frayne, 1967) . In addition Ting, Rodrigues and Herberman (1973) found no protection to challenge with polyomainduced tumour cells, using mice immunized with syngeneic irradiated mid-term foetal tissue. In contrast with these results are those of Coggin, Ambrose and Anderson (1970) showing that the presensitization to embryonic tissue could induce transplantation resistance to SV40 hamster tumours, and similar findings have recently been reported for chemically-induced tumours of mice, guinea-pigs and rats Le Mevel and Wells, 1973;  Grant, Ladisch and Wells, 1974) . Previous investigations in this laboratory into the immunogenicity of rat embryonic tissue have failed to substantiate the view that embryo-sensitized rats are capable of rejecting tumour cell implants (Baldwin, Glaves and Vose, 1974) . The disparity in the results of different workers may, however, be attributed to the different immunization procedures adopted, and the results presented here extend the initial observations to include a wide range of chemicallyinduced and spontaneous rat tumours, incorporating procedures shown previously to successfully induce tumour rejection in the rat when tumour cells are used for immunization. The nature of the immune response in embryo-sensitized rats was studied using in vitro assays to detect cell-mediated immune responses, and the relevance of these findings is discussed in relation to in vivo tumour rejection.
MATERIAL AND METHODS
Rats and tumours.-Hepatomata induced in Wistar rats by oral administration of 4-dimethylaminoazobenzene (DAB) were maintained by serial transplantation into syngeneic rats of the same sex as the tumour donor' (Baldwin and Barker, 1967) . Rat sarcomata were induced by s.c. injection of 3-methylcholanthrene (Mc), and a mammary carcinoma AAF57 by oral administration of 2-acetylaminofluorene as previously described (Baldwin and Embleton, 1969 (Witschi. 1956 ) were removed aseptically from multiparous pregnant rats, finely minced and pressed through an 80-gauge stainless steel mesh, and suspended in Hanks' balanced salt solution. The viable cell count was determined and adjusted to 1 x 107 cells/ml. Cells prepared by this method were 70-90% viable. Spleen cells were prepared as described above, and used as normal control cells. The cell suspensions were then irradiated (5000 rad) and inoculated into groups of rats; 02 ml of rat embryo or adult rat spleen cells was inoculated s.c., and 01 ml of cells i.p., weekly for up to 5 weeks. Immunizations were carried out within 1 h of the embryos being removed. Ten days after the final immunizing dose, rats were challenged subcutaneously with a minimal tumour-producing dose, and the incidence and growth of tumours recorded up to the sixth week.
Irradiated rat embryo grafts.-Rat embryos (14-15 days old) were removed aseptically, sectioned into 4 fragments and irradiated (5000 rad); the fragments were implanted into anaesthetized rats, at weekly intervals, for up to 5 weeks. Control rats received irradiated adult rat spleen tissue fragments. Both groups of rats were challenged 10 days after the final implantation, with a minimal tumour cell inoculum.
Embryoma excision. Single cell suspensions were prepared from 14-15-day-old rat embryos and 5 x 106 viable cells inoculated s.c. into groups of rats. The resulting embryomata were then excised at 1-2 cm in diameter, and 10 days following excision the rats were used in experiments.
Adoptive transfer experiments.-LNC and spleen cells were prepared from embryosensitized rats and mixed together with trypsinized rat tumour cells prepared from solid tumour fragments, in ratios of 500: 1 to 5000 : 1 (lymphoid cells : tumour cells). The mixture (0-2 ml) was then inoculated into normal recipients and the incidence of tumours recorded over a period of 5 weeks.
Conitrol rats received tumour cells and lymphoid cells prepared from normal (nonsensitized) rats or rats having received implants of normal adult rat tissue.
RESULTS
Incidence of tumours following immunization with irradiated (5000 rad) 14-15-dayold rat embryo cells
The incidence of tumours in rats immunized with up to 5 s.c. and i.p. inoculations of irradiated 14-15-day-old rat embryo cells is shown in Table I (Table I, Expts. 3-6), and using tumours of varying histological types, no protection to challenge was afforded by prior immunization with irradiated rat embryo cells. In only one experiment, using hepatoma D30 cells for challenge, was there a reduction in the rate of tumour growth, although the final tumour incidence in both test and controls was similar (Table I, Expt. 3).
Incidence of tumours following immunization with irradiated (5000 rad) 14-15-dayold rat embryo grafts Rats having received 4-5 irradiated 14-15-day-old rat embryo grafts, were challenged s.c. with tumour cells from chemically-induced hepatoma D23 and mammary carcinoma AAF57, and spontaneous sarcomata (Sp24 and Sp4l) and mammary carcinomata (Sp4 and Sp15). The incidence of tumours is shown in Table II . Only embryo-immunized rats challenged with mammary carcinoma AAF57 showed any significant protection to tumour challenge (Table II 10/10 10/10 7/10 9/9 8/10 6/9 * Tumour cells inoculated s.c. in 0 -2 ml. t Final incidence of tumours 4-6 weeks after tumour cell challenge.
$ Number developing tumours/number inoculated. § 4-5 grafts of rat embryos aged 14-16 days.
T 4-5 grafts normal female rat spleen.
Significant reduction in the incidence of tumour (P < 0 05). t Final incidence of tumours 4-6 weeks after adoptive transfer. t Significant reduction in the incidence and growth rate of tumours (P < 0 05). normal (non-sensitized) controls, is shown in Table III . Using hepatoma D23 cells and LNC or spleen cells from embryosensitized rats, inhibition of tumour growth was observed in only 3 out of 7 experiments performed (Table III, Expts. 1-7). Lymphoid cells from rats immunized with irradiated rat embryo cells failed to inhibit the development and growth of mammary carcinoma AAF57 cells used at a 3000: 1 or 2000: 1 ratio (lymphoid cells: tumour cells).
In vitro cytotoxicity of lymphoid cells from embryo-immunized rats Spleen cells and LNC taken from embryoma-excised rats and rats immunized with 3-5 weekly inoculations of 14-15-day-old rat embryo cells were tested for in vitro cytotoxicity towards tumour, embryo and normal rat target cells (Table IV) (Baldwin et al., 1973; Rees, Bray, Robins and Baldwin, 1975 Le Mevel and Wells, 1973; Parmiani and Lembo, 1974; Bendick, Borenfreund and Stonehill, 1973; Baldwin et al., 1973) . This may in part reflect differences between the tumour systems studied as well as differences in the embryonic tissue used, or its method of preparation. The present study was designed further to evaluate the immune status of rats immunized with rat embryonic tissue. Experimental rat tumours of various histological types were used, and methods previously shown to induce transplant immunity to tumour challenge were incorporated into the study. The results presented here show tumour rejection responses in rats immunized with irradiated 14-15-day-old rat embryonic tissue or cells, to be an inconsistent event, in both the direct challenge experiments and cell transfer tests This low frequency of reactivity was shown using direct challenge and adoptive cell transfer with hepatoma D23 and mammary carcinoma AAF57 tumour systems, and is consistent with previous results obtained with chemicallyinduced rat sarcomata . Immunity to challenge with spontaneous rat mammary carcinomata and sarcomata could not be demonstrated in rats sensitized to rat embryonic tissue, although these tumours have been shown to express embryonic components at their cell surface (Baldwin and Embleton, 1974) .
Possible explanations as to why embryo-immunized rats fail consistently to limit the growth of tumours known to express embryonic components may be proposed. Firstly, threshold differences in immunity may determine the fate of tumour cells implanted s.c., and the level of immunity may be directly dependent on the amount of tumour-related embryonic antigen present in the immunizing inoculum. The way in which the antigens are presented to the host may also be an important factor, not only in determining the level, but also the nature of the immune responses. Tumourassociated embryonic antigen expression on rat embryo cells has been shown to be phase-specific, being maximally expressed on rat embryos aged 14-15 days. Although the tissue used in the present study for immunization was derived from 14-15-day-old rat embryos, this does not eliminate the possibility that variation in the immunogenicity of tissue preparations may have occurred, and as such may have affected the nature of the immune response. Coggin and Anderson (1974) have suggested that embryonic tissue derived from multiparous animals is less likely to evoke tumour resistance, compared with embryonic tissue prepared from primiparous animals. This is unlikely to be the case in the rat model, since previous work has established no increased resistance following immunization with primiparous rat embryonic tissue .
Recent work has shown that presensitization to 14-15-day-old rat embryonic tissue limits the growth of tumour cells inoculated i.v. into rats (Rees, Shah and Baldwin, 1975; Shah et al., in preparation) . In these experiments rats were immunized by embryoma excision, or by 3 weekly inoculations of irradiated rat embryo cells or extranuclear membranes prepared from 14-15-day-old rat embryos. These immunizations effectively prevented the growth of pulmonary tumours compared with non-immunized control rats, or rats immunized with adult rat tissue or 19-20-day-old embryonic tissue. This suggests that the route by which tumour cells are implanted may be an important variable in demonstrating anti-tumour responses. Such results, compared with those presented here, indicate inhibition of pulmonary tumour growth to be a more sensitive assay system for measuring immunity in animals immunized with embryonic tissue. The mechanism of this inhibition has not yet been fully established, and is currently under investigation.
